Oregon doctors were paid collectively $24.5 million by drug and device manufacturers between August 2013 and December 2014, according to a ProPublica analysis.
ProPublica crunched data on payments to 685,000 doctors and 1,135 teaching hospitals across the U.S., given by 1,565 companies. In so doing, the news organization was able to show a relationship between payments and prescribing patterns.
The more money doctors receive, on average, the more brand-name medications they prescribe. In fact, doctors who received industry payments were two-to-three times as likely to prescribe brand-name drugs “at exceptionally high rates as others in their specialty,” ProPublica found.